1. American Diabetes Association. Standards of medical care in diabetes—2009. Diabetes Care. 2009;32(suppl 1):S13–S61.
2. Saberi F, Heyland D, Lam L, et al. Prevalence, incidence, and clinical resolution of insulin resistance in critically ill patients: an observational study. J Parenter Enteral Nutr. 2008;32:227–235.
3. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clinic Proc. 2003;78:1471–1478.
4. Van den Berghe G. How does blood glucose control with insulin save lives in intensive care? J Clin Invest. 114:1187–1195, 2004.
5. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32:858–873.
6. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin. 2001;17:107–124.
7. Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 2003;31:359–366.
8. Sung J, Bochicchio GV, Joshi M, et al. Admission hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma Inj Infect Crit Care. 2005;59:80–83.
9. Young B, Ott L, Dempsy R, et al. Relationship between admission hyperglycemia and neurologic outcome of severely brain-injured patients. Ann Surg. 1989;210:466–472.
10. Weir CJ, Murray GD, Dyker AG, et al. Is hyperglycemia an independent risk predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ. 1997;314:1303–1306.
11. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359–1367.
12. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449–461.
13. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125–139.
14. Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care. 2009;35:1738–1748.
15. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–1297.
16. Kosiborod M, Inzucchi SE, Krumholz HM, et al. Glucometrics in patients with acute myocardial infarction. Defining the optimal outcome-based measure of risk. Circulation. 2008;117:1018–1027.
17. Deedwania P, Kosiborod M, Barret E, et al. Hyperglycemia and acute coronary syndrome. Circulation. 2008;117:1610–1619.
18. Timmer JR, Ottervanger JP, de Boer MJ, et al. Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2005;45:999–1002.
19. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischemia and arrhythmias. Lancet. 1994;343:155–158.
20. Malmberg K, Norhammar A, Wedel H, et al. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long–term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation. 1999;99:2626–2632.
21. Maimberg K, Ryden L, Wedel H, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26: 650–661.
22. Mehta SR, Yusuf S, Diaz R, et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA. 2005;293: 437–446.
23. Cheung, NW, Wong, VW, McLean M. The hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study. A randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care. 2006;29:765–770.
24. Furnary AP. Rationale for glycemic control in cardiac surgical patients: the Portland Diabetic Project. Insulin. 2006;1(suppl A):S24–S29.
25. Lindsberg PJ, Roine RO. Hyperglycemia in acute stroke. Stroke. 2004;35:363–364.
26. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32: 2426–2432.
27. Baird TA, Parsons MW, Phanh T, et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke. 2003;34:2208–2214.
28. Fuentes B, Castillo J, San Jose B, et al. The prognostic value of capillary glucose levels in acute stroke. The Glycemia in Acute Stroke (GLIAS) study. Stroke. 2009;40:562–568.
29. Gray CS, Hildreth AJ, Sandercock PA, et al. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol. 2007;6:397–406.
30. Bruno A, Kent TA, Coull BM, et al. Treatment of Hyperglycemia in Ischemic Stroke (THIS): a randomized pilot trial. Stroke. 2008;39:384–389.
31. Johnston KC, Hall CE, Kissela BM, et al. Glucose Regulation in Acute Stroke Patients (GRASP) trial: a randomized pilot trial. Stroke. 2009;40:3804–3809.
32. European Stroke Organization (ESO) Executive Committee, ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Available at: http://www.eso-stroke.org
33. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke. Stroke. 2007;38:1655–1711.
34. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med. 2007;35:2262–2267.
35. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med. 208;36:296–327.
36. Surviving sepsis guidelines. Surviving Sepsis Campaign statement on glucose control in severe sepsis. Available at: http://www.survivingsepsis.org
37. Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32:1119–1131.
38. Meijering S, Corstjens AM, Tulleken JE, et al. Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature. Crit Care. 2006;10:R19. Published online.
39. Nazer LH, Chow SL, Moghissi ES. Infusion protocols for critically ill patients: a highlight of differences and similarities. Endocr Pract. 2007;13:137–146.
40. Umpierrez, GE, Smiley, D, Zisman, A, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007;30:2181–2186.